|
1
|
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
|
N Engl J Med
|
2010
|
22.04
|
|
2
|
Transcatheter versus surgical aortic-valve replacement in high-risk patients.
|
N Engl J Med
|
2011
|
15.70
|
|
3
|
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
|
J Am Coll Cardiol
|
2004
|
5.67
|
|
4
|
Bivalirudin for patients with acute coronary syndromes.
|
N Engl J Med
|
2006
|
5.49
|
|
5
|
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
|
N Engl J Med
|
2007
|
5.37
|
|
6
|
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.
|
N Engl J Med
|
2012
|
4.47
|
|
7
|
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis.
|
J Am Coll Cardiol
|
2004
|
3.67
|
|
8
|
Long-term outcome of percutaneous coronary intervention for chronic total occlusions.
|
JACC Cardiovasc Interv
|
2011
|
3.38
|
|
9
|
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
|
JAMA
|
2007
|
3.07
|
|
10
|
Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging.
|
JAMA
|
2010
|
2.97
|
|
11
|
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
|
Lancet
|
2007
|
2.67
|
|
12
|
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.
|
J Am Coll Cardiol
|
2005
|
2.56
|
|
13
|
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.
|
J Am Coll Cardiol
|
2008
|
2.54
|
|
14
|
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
|
Circulation
|
2009
|
2.47
|
|
15
|
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
|
Am J Cardiol
|
2005
|
2.42
|
|
16
|
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
|
Circulation
|
2009
|
2.40
|
|
17
|
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
|
Circulation
|
2004
|
2.35
|
|
18
|
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis.
|
JACC Cardiovasc Interv
|
2009
|
2.30
|
|
19
|
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
|
Circulation
|
2004
|
2.28
|
|
20
|
Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.
|
J Am Coll Cardiol
|
2005
|
2.19
|
|
21
|
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.
|
J Am Coll Cardiol
|
2007
|
2.14
|
|
22
|
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization.
|
J Am Coll Cardiol
|
2006
|
2.12
|
|
23
|
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention.
|
J Invasive Cardiol
|
2010
|
2.10
|
|
24
|
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.
|
JACC Cardiovasc Interv
|
2012
|
2.08
|
|
25
|
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina?
|
Catheter Cardiovasc Interv
|
2003
|
2.06
|
|
26
|
Cause of death with bare metal and sirolimus-eluting stents.
|
Eur Heart J
|
2006
|
2.04
|
|
27
|
The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization.
|
J Am Coll Cardiol
|
2010
|
1.90
|
|
28
|
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
|
Circulation
|
2004
|
1.87
|
|
29
|
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
|
J Am Coll Cardiol
|
2009
|
1.86
|
|
30
|
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
|
JAMA
|
2007
|
1.84
|
|
31
|
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
|
Circulation
|
2004
|
1.83
|
|
32
|
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study.
|
J Am Coll Cardiol
|
2005
|
1.73
|
|
33
|
Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis.
|
J Am Coll Cardiol
|
2005
|
1.72
|
|
34
|
Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis.
|
Circulation
|
2004
|
1.72
|
|
35
|
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
|
J Am Coll Cardiol
|
2009
|
1.70
|
|
36
|
Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
|
Catheter Cardiovasc Interv
|
2002
|
1.66
|
|
37
|
Subintimal tracking and re-entry technique with contrast guidance: a safer approach.
|
Catheter Cardiovasc Interv
|
2008
|
1.66
|
|
38
|
In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry.
|
Eur Heart J
|
2008
|
1.65
|
|
39
|
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study.
|
J Am Coll Cardiol
|
2003
|
1.62
|
|
40
|
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.
|
Circulation
|
2005
|
1.60
|
|
41
|
Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft.
|
Am J Cardiol
|
2006
|
1.59
|
|
42
|
Mechanical complications of everolimus-eluting stents associated with adverse events: an intravascular ultrasound study.
|
EuroIntervention
|
2014
|
1.57
|
|
43
|
Short- and long-term results after multivessel stenting in diabetic patients.
|
J Am Coll Cardiol
|
2004
|
1.57
|
|
44
|
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions.
|
Kidney Int
|
2005
|
1.57
|
|
45
|
The truth and consequences of the COURAGE trial.
|
J Am Coll Cardiol
|
2007
|
1.55
|
|
46
|
Dual catheter technique for the treatment of severe coronary artery perforations.
|
Catheter Cardiovasc Interv
|
2010
|
1.55
|
|
47
|
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
|
Circulation
|
2004
|
1.54
|
|
48
|
Safety and performance of targeted renal therapy: the Be-RITe! Registry.
|
J Endovasc Ther
|
2009
|
1.54
|
|
49
|
Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial.
|
J Am Coll Cardiol
|
2004
|
1.53
|
|
50
|
Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial.
|
J Am Coll Cardiol
|
2012
|
1.51
|
|
51
|
Feasibility and safety of the second-generation, frequency domain optical coherence tomography (FD-OCT): a multicenter study.
|
J Invasive Cardiol
|
2012
|
1.47
|
|
52
|
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention.
|
J Invasive Cardiol
|
2007
|
1.46
|
|
53
|
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.
|
Circulation
|
2005
|
1.46
|
|
54
|
Value of drug-eluting stents in cardiac transplant recipients.
|
Am J Cardiol
|
2009
|
1.45
|
|
55
|
Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis.
|
J Am Coll Cardiol
|
2005
|
1.44
|
|
56
|
Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion.
|
Catheter Cardiovasc Interv
|
2003
|
1.42
|
|
57
|
Impact of target vessel on long-term survival after percutaneous coronary intervention for chronic total occlusions.
|
Catheter Cardiovasc Interv
|
2013
|
1.41
|
|
58
|
Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (≥75 years): five-year outcomes from a 1,791 patient multi-national registry.
|
Catheter Cardiovasc Interv
|
2013
|
1.40
|
|
59
|
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
|
Catheter Cardiovasc Interv
|
2008
|
1.39
|
|
60
|
Acute angiographic and clinical results of the NIR w/SOX stent.
|
J Invasive Cardiol
|
2002
|
1.39
|
|
61
|
A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial.
|
Catheter Cardiovasc Interv
|
2013
|
1.39
|
|
62
|
Novel method for extraction of a massive refractory coronary thrombus after stent implantation.
|
Catheter Cardiovasc Interv
|
2005
|
1.39
|
|
63
|
Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients.
|
Catheter Cardiovasc Interv
|
2012
|
1.39
|
|
64
|
Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study.
|
J Invasive Cardiol
|
2016
|
1.38
|
|
65
|
In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.
|
JACC Cardiovasc Imaging
|
2009
|
1.37
|
|
66
|
Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial.
|
JACC Cardiovasc Interv
|
2012
|
1.35
|
|
67
|
Association of plaque characterization by intravascular ultrasound virtual histology and arterial remodeling.
|
Am J Cardiol
|
2005
|
1.32
|
|
68
|
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association.
|
Circulation
|
2005
|
1.30
|
|
69
|
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
|
J Am Coll Cardiol
|
2009
|
1.26
|
|
70
|
Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture.
|
Am J Cardiol
|
2009
|
1.23
|
|
71
|
Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.
|
J Am Coll Cardiol
|
2009
|
1.22
|
|
72
|
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.
|
Eur Heart J
|
2009
|
1.21
|
|
73
|
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.
|
Circulation
|
2004
|
1.20
|
|
74
|
Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located?
|
Circ Cardiovasc Interv
|
2010
|
1.19
|
|
75
|
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
|
Am Heart J
|
2004
|
1.19
|
|
76
|
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
|
J Am Coll Cardiol
|
2006
|
1.18
|
|
77
|
Assessing intermediate left main coronary lesions using intravascular ultrasound.
|
Am Heart J
|
2007
|
1.18
|
|
78
|
Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support.
|
J Card Surg
|
2011
|
1.16
|
|
79
|
Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes.
|
Circulation
|
2003
|
1.16
|
|
80
|
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
|
J Am Coll Cardiol
|
2009
|
1.16
|
|
81
|
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial.
|
J Thorac Cardiovasc Surg
|
2012
|
1.12
|
|
82
|
Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results.
|
Catheter Cardiovasc Interv
|
2005
|
1.12
|
|
83
|
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
|
J Am Coll Cardiol
|
2008
|
1.11
|
|
84
|
Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques.
|
Am J Cardiol
|
2005
|
1.09
|
|
85
|
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.
|
Circulation
|
2002
|
1.08
|
|
86
|
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
|
J Am Coll Cardiol
|
2009
|
1.07
|
|
87
|
Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery.
|
Am J Cardiol
|
2008
|
1.07
|
|
88
|
Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.
|
Am J Cardiol
|
2004
|
1.05
|
|
89
|
Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial).
|
Am J Cardiol
|
2011
|
1.05
|
|
90
|
Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.
|
Circulation
|
2005
|
1.04
|
|
91
|
Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease.
|
Am J Cardiol
|
2006
|
1.03
|
|
92
|
Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
|
Circulation
|
2004
|
1.01
|
|
93
|
Contemporary principles of coronary chronic total occlusion recanalization.
|
Catheter Cardiovasc Interv
|
2010
|
1.00
|
|
94
|
Transplantation of autologous endothelial cells induces angiogenesis.
|
Pacing Clin Electrophysiol
|
2003
|
1.00
|
|
95
|
Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis.
|
Clin Cardiol
|
2012
|
0.99
|
|
96
|
Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents.
|
JACC Cardiovasc Interv
|
2011
|
0.98
|
|
97
|
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.
|
J Am Coll Cardiol
|
2002
|
0.98
|
|
98
|
Luminal narrowing due to intramural hematoma shift from left anterior descending coronary artery to left circumflex artery.
|
Catheter Cardiovasc Interv
|
2004
|
0.98
|
|
99
|
Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome.
|
Am J Cardiol
|
2007
|
0.97
|
|
100
|
Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions.
|
Catheter Cardiovasc Interv
|
2004
|
0.97
|
|
101
|
Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review.
|
J Am Coll Cardiol
|
2011
|
0.97
|
|
102
|
Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
|
JACC Cardiovasc Interv
|
2009
|
0.96
|
|
103
|
Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives.
|
Semin Thorac Cardiovasc Surg
|
2006
|
0.96
|
|
104
|
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.
|
Am J Cardiol
|
2008
|
0.96
|
|
105
|
Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
|
J Am Coll Cardiol
|
2012
|
0.95
|
|
106
|
Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions.
|
Am J Cardiol
|
2004
|
0.95
|
|
107
|
Procedural implications of intravascular ultrasound morphologic features of chronic total coronary occlusions.
|
Am J Cardiol
|
2006
|
0.94
|
|
108
|
Radiation is not the only risk.
|
AJR Am J Roentgenol
|
2011
|
0.94
|
|
109
|
Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
|
JACC Cardiovasc Interv
|
2012
|
0.93
|
|
110
|
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.
|
J Am Coll Cardiol
|
2006
|
0.92
|
|
111
|
Intravascular ultrasound assessment of drug-eluting stent expansion.
|
Am Heart J
|
2007
|
0.92
|
|
112
|
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
|
J Am Coll Cardiol
|
2008
|
0.92
|
|
113
|
In vivo intravascular ultrasonic assessment of anomalous right coronary artery arising from left coronary sinus.
|
Am J Cardiol
|
2009
|
0.91
|
|
114
|
A novel technique for ultra-low contrast administration during angiography or intervention.
|
Catheter Cardiovasc Interv
|
2010
|
0.91
|
|
115
|
Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation.
|
JACC Cardiovasc Interv
|
2011
|
0.91
|
|
116
|
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study.
|
J Am Coll Cardiol
|
2003
|
0.90
|
|
117
|
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
|
Am Heart J
|
2011
|
0.90
|
|
118
|
Impact of myocardial bridge on clinical outcome after coronary stent placement.
|
Am J Cardiol
|
2009
|
0.89
|
|
119
|
Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts.
|
Am J Cardiol
|
2005
|
0.89
|
|
120
|
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
|
Am J Cardiol
|
2008
|
0.89
|
|
121
|
Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures.
|
Am J Cardiol
|
2012
|
0.88
|
|
122
|
Intravascular ultrasound profile analysis of ruptured coronary plaques.
|
Am J Cardiol
|
2006
|
0.88
|
|
123
|
Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon.
|
Am J Cardiol
|
2007
|
0.87
|
|
124
|
Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
|
Catheter Cardiovasc Interv
|
2005
|
0.87
|
|
125
|
Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusions.
|
JACC Cardiovasc Interv
|
2009
|
0.87
|
|
126
|
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.
|
Am J Cardiol
|
2006
|
0.87
|
|
127
|
A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
|
Am J Cardiol
|
2006
|
0.86
|
|
128
|
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
|
Am J Cardiol
|
2006
|
0.86
|
|
129
|
Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus.
|
Am J Cardiol
|
2011
|
0.86
|
|
130
|
Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
|
JACC Cardiovasc Interv
|
2010
|
0.86
|
|
131
|
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.
|
JACC Cardiovasc Interv
|
2009
|
0.86
|
|
132
|
Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial).
|
Am J Cardiol
|
2005
|
0.86
|
|
133
|
Gender-specific outcomes after sirolimus-eluting stent implantation.
|
J Am Coll Cardiol
|
2007
|
0.86
|
|
134
|
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation.
|
JACC Cardiovasc Interv
|
2009
|
0.85
|
|
135
|
Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
|
Catheter Cardiovasc Interv
|
2005
|
0.85
|
|
136
|
Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes.
|
Am J Cardiol
|
2009
|
0.85
|
|
137
|
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial.
|
J Thromb Thrombolysis
|
2011
|
0.85
|
|
138
|
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
|
Am J Cardiol
|
2007
|
0.85
|
|
139
|
Left main drug-eluting stents: natural progression or a bridge too far?
|
J Am Coll Cardiol
|
2007
|
0.85
|
|
140
|
The axial distribution of lesion-site atherosclerotic plaque components: an in vivo volumetric intravascular ultrasound radio-frequency analysis of lumen stenosis, necrotic core and vessel remodeling.
|
Ultrasound Med Biol
|
2008
|
0.85
|
|
141
|
Selection of coronary stents.
|
J Am Coll Cardiol
|
2002
|
0.85
|
|
142
|
Coronary artery disease and aortic stenosis in the transcatheter aortic valve replacement era: old questions, new paradigms: the evolving role of percutaneous coronary intervention in the treatment of patients with aortic stenosis.
|
Circulation
|
2012
|
0.84
|
|
143
|
Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis.
|
Am J Cardiol
|
2011
|
0.84
|
|
144
|
Comparative effectiveness of revascularization strategies.
|
N Engl J Med
|
2012
|
0.84
|
|
145
|
New percutaneous approaches for chronic total occlusion of coronary arteries.
|
Expert Rev Cardiovasc Ther
|
2007
|
0.84
|
|
146
|
Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model.
|
J Am Coll Cardiol
|
2002
|
0.83
|
|
147
|
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.
|
JACC Cardiovasc Imaging
|
2012
|
0.83
|
|
148
|
A virtual histology intravascular ultrasound analysis of coronary chronic total occlusions.
|
Catheter Cardiovasc Interv
|
2012
|
0.83
|
|
149
|
Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions.
|
Am J Cardiol
|
2004
|
0.83
|
|
150
|
Update on drug-eluting coronary stents.
|
Expert Rev Cardiovasc Ther
|
2005
|
0.83
|
|
151
|
The accuracy of length measurements using different intravascular ultrasound motorized transducer pullback systems.
|
Int J Cardiovasc Imaging
|
2007
|
0.83
|
|
152
|
Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion.
|
Am J Cardiol
|
2010
|
0.83
|
|
153
|
Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound.
|
Am J Cardiol
|
2006
|
0.82
|
|
154
|
Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old.
|
Am J Cardiol
|
2003
|
0.82
|
|
155
|
Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation.
|
Am J Cardiol
|
2005
|
0.81
|
|
156
|
Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions.
|
J Endovasc Ther
|
2004
|
0.81
|
|
157
|
Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III).
|
Am J Cardiol
|
2003
|
0.81
|
|
158
|
Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%.
|
Am J Cardiol
|
2003
|
0.80
|
|
159
|
Percutaneous revascularization of chronic total coronary occlusions: are the benefits underappreciated?
|
JACC Cardiovasc Interv
|
2012
|
0.80
|
|
160
|
Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries.
|
Am J Cardiol
|
2003
|
0.80
|
|
161
|
Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors.
|
Am J Cardiol
|
2002
|
0.80
|
|
162
|
Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model.
|
Catheter Cardiovasc Interv
|
2002
|
0.79
|
|
163
|
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
|
Am J Cardiol
|
2007
|
0.79
|
|
164
|
Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.
|
J Invasive Cardiol
|
2016
|
0.79
|
|
165
|
Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation.
|
Am J Cardiol
|
2005
|
0.79
|
|
166
|
Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture.
|
Am Heart J
|
2006
|
0.79
|
|
167
|
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial.
|
Circulation
|
2002
|
0.79
|
|
168
|
Virtual histology intravascular ultrasound comparison of coronary chronic total occlusions versus non-occlusive lesions.
|
Int J Cardiovasc Imaging
|
2013
|
0.79
|
|
169
|
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
|
Am J Cardiol
|
2007
|
0.78
|
|
170
|
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis.
|
Am J Cardiol
|
2003
|
0.78
|
|
171
|
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).
|
Am J Cardiol
|
2006
|
0.78
|
|
172
|
Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model.
|
Cardiovasc Radiat Med
|
2004
|
0.78
|
|
173
|
Intracoronary radiation to treat in-stent restenosis in six cardiac transplant patients.
|
Catheter Cardiovasc Interv
|
2003
|
0.78
|
|
174
|
An intravascular ultrasound comparison of left anterior descending artery/first diagonal branch versus distal left main coronary artery bifurcation lesions.
|
EuroIntervention
|
2013
|
0.78
|
|
175
|
Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris.
|
Am J Cardiol
|
2003
|
0.78
|
|
176
|
Patient radiation exposure during transcatheter aortic valve replacement procedures.
|
EuroIntervention
|
2012
|
0.78
|
|
177
|
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials.
|
EuroIntervention
|
2009
|
0.78
|
|
178
|
Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound.
|
Am J Cardiol
|
2004
|
0.78
|
|
179
|
Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis.
|
Am J Cardiol
|
2006
|
0.78
|
|
180
|
Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions.
|
J Invasive Cardiol
|
2012
|
0.77
|
|
181
|
Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study).
|
Am J Cardiol
|
2005
|
0.77
|
|
182
|
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
|
Am Heart J
|
2011
|
0.77
|
|
183
|
Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention.
|
Am J Cardiol
|
2003
|
0.77
|
|
184
|
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study.
|
J Am Coll Cardiol
|
2013
|
0.77
|
|
185
|
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
|
Am J Cardiol
|
2005
|
0.77
|
|
186
|
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
|
Catheter Cardiovasc Interv
|
2004
|
0.77
|
|
187
|
Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque.
|
Am J Cardiol
|
2005
|
0.77
|
|
188
|
Is surgery preferred for the diabetic with multivessel disease? Debate on revascularization strategy for diabetic patients with multivessel coronary artery disease.
|
Circulation
|
2005
|
0.77
|
|
189
|
Optical coherence tomographic evaluation of transplant coronary artery vasculopathy with correlation to cellular rejection.
|
Circ Cardiovasc Interv
|
2014
|
0.77
|
|
190
|
Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts.
|
Am J Cardiol
|
2006
|
0.77
|
|
191
|
Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry).
|
Am J Cardiol
|
2010
|
0.76
|
|
192
|
Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing.
|
Am J Cardiol
|
2003
|
0.76
|
|
193
|
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial.
|
Eur J Cardiovasc Prev Rehabil
|
2011
|
0.76
|
|
194
|
Cardiogenic shock in acute myocardial infarction.
|
Catheter Cardiovasc Interv
|
2003
|
0.76
|
|
195
|
Role of PLA2 polymorphism on clinical events after percutaneous coronary intervention.
|
Acute Card Care
|
2009
|
0.76
|
|
196
|
Clinical applications of a new Enhanced Stent Imaging technology.
|
Catheter Cardiovasc Interv
|
2013
|
0.75
|
|
197
|
Prevalence and anatomical features of acute longitudinal stent deformation: An intravascular ultrasound study.
|
Catheter Cardiovasc Interv
|
2014
|
0.75
|
|
198
|
Interventional cardiology: How should the appropriateness of PCI be judged?
|
Nat Rev Cardiol
|
2011
|
0.75
|
|
199
|
Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome.
|
Am J Cardiol
|
2004
|
0.75
|
|
200
|
Left main percutaneous coronary intervention crossing the threshold: time for a guidelines revision!
|
J Am Coll Cardiol
|
2009
|
0.75
|
|
201
|
Assessing the durability of durable stent polymers: will they pass the test of time?
|
J Interv Cardiol
|
2011
|
0.75
|
|
202
|
A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stenting.
|
J Invasive Cardiol
|
2006
|
0.75
|
|
203
|
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
|
EuroIntervention
|
2016
|
0.75
|
|
204
|
Multiple ulcerations in plaque behind stent struts resulting in late stent malapposition after gamma brachytherapy for in-stent restenosis.
|
J Invasive Cardiol
|
2003
|
0.75
|
|
205
|
Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
|
Int J Cardiol
|
2008
|
0.75
|
|
206
|
Bypass to the left coronary artery system may accelerate left main coronary artery negative remodeling and calcification.
|
Clin Res Cardiol
|
2013
|
0.75
|
|
207
|
Guiding Light: Insights Into Atherectomy by Optical Coherence Tomography.
|
JACC Cardiovasc Interv
|
2016
|
0.75
|
|
208
|
Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.
|
Clin Exp Pharmacol Physiol
|
2012
|
0.75
|
|
209
|
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).
|
Am J Cardiol
|
2010
|
0.75
|
|
210
|
Percutaneous coronary intervention in a sequential radial artery graft anastomosed to the descending aorta, left circumflex artery and obtuse marginal artery.
|
J Invasive Cardiol
|
2002
|
0.75
|
|
211
|
Approaches to percutaneous coronary intervention of right coronary artery chronic total occlusions: insights from a multicentre US registry.
|
EuroIntervention
|
2016
|
0.75
|
|
212
|
The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention.
|
J Invasive Cardiol
|
2017
|
0.75
|
|
213
|
Delayed restenosis after gamma brachytherapy for in-stent restenosis.
|
J Interv Cardiol
|
2004
|
0.75
|
|
214
|
Revascularization in heart failure: the role of percutaneous coronary intervention.
|
Heart Fail Clin
|
2007
|
0.75
|
|
215
|
Embolization containment device for a native coronary arterial lesion with large thrombus burden.
|
J Invasive Cardiol
|
2002
|
0.75
|
|
216
|
The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.
|
J Invasive Cardiol
|
2017
|
0.75
|
|
217
|
Local application of antisense for prevention of restenosis.
|
Methods Mol Med
|
2005
|
0.75
|
|
218
|
Characteristics of Early Versus Late In-Stent Restenosis in Second- Generation Drug-Eluting Stents: An Optical Coherence Tomography Study.
|
EuroIntervention
|
2017
|
0.75
|
|
219
|
Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter aortic valve replacement.
|
Circ Cardiovasc Interv
|
2013
|
0.75
|
|
220
|
Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
221
|
Magnetic positioning system in coronary angiography and percutaneous intervention: a feasibility and safety study.
|
Catheter Cardiovasc Interv
|
2013
|
0.75
|
|
222
|
Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry.
|
J Invasive Cardiol
|
2016
|
0.75
|
|
223
|
Novel applications of noncardiac vascular devices for the treatment of coronary artery pathology.
|
J Invasive Cardiol
|
2009
|
0.75
|
|
224
|
Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age.
|
Am J Cardiol
|
2003
|
0.75
|
|
225
|
Cutting Balloon angioplasty for underexpanded stent deployed through struts of previously implanted stent.
|
J Invasive Cardiol
|
2002
|
0.75
|
|
226
|
Frequency and determinants of black holes in sirolimus-eluting stent restenosis.
|
J Invasive Cardiol
|
2006
|
0.75
|
|
227
|
Intravascular ultrasound findings of stent fractures in patients with Sirolimus- and Paclitaxel-eluting stents.
|
Am J Cardiol
|
2010
|
0.75
|
|
228
|
Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation.
|
Am J Cardiol
|
2005
|
0.75
|
|
229
|
The association between experience and proficiency with robotic-enhanced coronary intervention-insights from the PRECISE multi-center study.
|
Acute Card Care
|
2014
|
0.75
|
|
230
|
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis.
|
J Invasive Cardiol
|
2007
|
0.75
|
|
231
|
Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
232
|
Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions.
|
Am J Cardiol
|
2004
|
0.75
|
|
233
|
Is the end of restenosis the beginning of a new era?
|
Ital Heart J
|
2004
|
0.75
|
|
234
|
Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study).
|
Am J Cardiol
|
2005
|
0.75
|
|
235
|
Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis.
|
Am J Cardiol
|
2003
|
0.75
|
|
236
|
Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible?
|
Am J Cardiol
|
2010
|
0.75
|
|
237
|
Enhanced stent imaging improves the diagnosis of stent underexpansion and optimizes stent deployment.
|
Catheter Cardiovasc Interv
|
2012
|
0.75
|
|
238
|
Proceedings of TCT: year in review: interventional field sees major developments in 2006.
|
J Interv Cardiol
|
2007
|
0.75
|
|
239
|
Robotic-Enhanced PCI Compared to the Traditional Manual Approach.
|
J Invasive Cardiol
|
2014
|
0.75
|
|
240
|
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).
|
Am J Cardiol
|
2006
|
0.75
|
|
241
|
Evidence based management of patients undergoing PCI. Conclusion.
|
Catheter Cardiovasc Interv
|
2010
|
0.75
|